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INTRODUCTION
Heart tumors are rare primary tumors with benign
heart tumors (BHTs) accounting for a majority of
these tumors.1 BHTs have several subtypes and differ
by age.1,2 Pediatric cases tend to be either
rhabdomyomas or fibromas.1,3,4 In adults, the most
common BHT is left atrial myxoma.1-3
Symptoms of these tumors are dependent on the
size and location of tumor.2,3 In approximately a third
of cases, the tumor has non-specific cardiac symptoms
include dyspnea, syncope and arrhythmias.1,5
Furthermore, BHTs have the potential to mimic other
cardiac conditions by causing embolisms leading to
cerebrovascular events or heart failure depending on
tumor size and location.1,2,5 The mimicry of these
tumors and non-specific symptoms can cause
diagnosis to be difficult. Once these tumors are
diagnosed, treatment is straightforward. Most often
the tumor is resected in adults, unless surgery is
contraindicated by underlying health conditions.2,3 In
pediatric cases, resection of the tumor is possible but
it may not be necessary because rhabdomyomas tend
to decrease in size over time.4 Even with all this
clinical information, data on the incidence of BHTs is
limited. Knowledge of the incidence of BHTs is
necessary to understand a potential source of cardiac
disease that may be underdiagnosed. Currently
available estimates stem from autopsy or surgery
studies or from a single hospital or registry.6-10 Each of
these presents a limited picture of the incidence. To
alleviate this issue, we describe the incidence as well
as demographic and clinical characteristics of all
patients diagnosed with BHT’s from 1988 to 2012 in
Florida.
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METHODS
Florida’s Center for Health Information and
Transparency (FCHIT) provided these data for the
analysis. Briefly, FCHIT is a branch of Florida’s
Agency for Healthcare Administration that collects
discharge data from all Floridian hospitals. We
utilized discharge data for inpatient records collected
from 1988 to 2012. In total, we reviewed over 55
million
discharge
records
for
inpatient
hospitalization. We reviewed each record’s principal
ICD-9 diagnosis code. We looked for ICD-9 code
212.7 to indicate if a patient was diagnosed with a
BHT. To be consistent with the literature, we used
212.7 as our main diagnostic code rather than
searching for tumor specific codes since they were
unavailable in these data. From these data,
demographic and clinical data were obtained. Using
only Florida residents, we estimated the yearly
incidence of these BHTs. We used age adjustment to
account for population differences using the 2000
United States Census population counts. We
standardized to the 2000 Census to be consistent with
the literature and to have a constant standard
population. All other descriptive statistics of the cases
include a mix of Floridian and non-Floridian
residents.
Basic demographic characteristics included: age
at diagnosis, sex, and race. We collapsed race into
three categories, white, black, and other minority
races. Clinical characteristic included: admitting
diagnosis (patients after 2005 only), admission type,
length of stay, and status at discharge. We categorized
admitting diagnosis based on the major organ systems
of the body and using the ICD-9 broad diagnosis
categories. We created five categories for status at
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discharge including died in hospital, home or
homecare, short and intermediate inpatient care,
long-term inpatient care, and other. Other included
other institutions such as hospice and psychiatric care
etc. We performed all statistical analyses in SAS
version 9.4 (SAS Institute, Cary N.C.).

RESULTS
Overall, 1656 BHTs were diagnosed in Florida
from 1988 to 2012. The incidence of these tumors
increased (Figure 1

Figure 1. Age- adjusted incidence rates of Benign Heart Tumors among hospital discharge data from Florida
between 1988 and 2012.a

a

Incidence rates are age-adjusted to the 2000 U.S. Census.

The average yearly age-adjusted incidence of these
tumors among Florida residents was 3.17 per one
million (standard deviation (SD): 0.97). Women had
twice as many of these tumors than men (Table 1).
The average age-adjusted yearly incidence was 1.95
per one million in men (SD: 0.66) while women had
an average age-adjusted yearly incidence of 4.35 per
one million people (SD: 1.45). Our sample was
predominately white (84.8%) and female (69.2%).
While the median age of onset was 63 years (Range:
0 - 96). Age of onset does appear to be bimodal with
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a peak occurring in children less than 10 years old
and in adults in their sixties and seventies. Patients
generally had a brief length of stay (<10 days) with
46.9% of patients being discharged to home or selfcare. Approximately 2.5% of patients diagnosed with
a BHT died in hospital. Of the patients whose
admitting diagnosis were reported, a majority
(55.9%) of them were admitted for either a benign or
malignant tumor with another 16.6% were admitted
for a disease of the circulatory system (Data not
shown).
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Table 1. Basic demographic and clinical characteristics of patients with a primary diagnosis of Benign Heart
Tumors in Florida hospitals from 1988 to 2012.
Characteristic
n
%
Sex
Female
1146
69.2%
Male
510
30.8%
Age (in years)

<10
10-19
20-29
30-39
40-49
50-59
60-69
70-79
80+

53
21
31
90
197
284
433
382
165

3.2%
1.3%
1.9%
5.4%
11.9%
17.1%
26.1%
23.1%
10.0%

Race a

White
Black
Other
Missing

1279
159
64
154

85.2%
10.6%
4.3%

Ethnicity

Hispanic
Non-Hispanic
Missing

158
1338
160

10.6%
89.4%

Resident status b

Florida
Other
Missing

1572
69
15

95.8%
4.2%

Admission type c

Emergency
Urgent
Elective
Newborn/Other

438
497
711
10

26.4%
30.0%
42.9%
0.6%

Discharge status d

Died
Home or Homecare
Short & Intermediate Inpatient
Long-term care
Other

41
1282
158
124
51

2.5%
77.4%
9.5%
7.5%
3.1%

7

Range
0 - 201

Length of stay (in days)

Median

a

Other category of race includes Asian, American Indian or Alaskan Native, and anyone reporting their race as
other.
b
Other resident status includes anyone who stated their home state was not Florida.
c
Other admission type are those admission not covered by the other four categories.
d
Other status at discharge would include institutions not covered by the other four categories, including Hospice,
psychiatric institutions, and Medicare institutions.
DISCUSSION & CONCLUSION
In our study, the incidence of BHTs increased
over time and women consistently had higher
incidences of these tumors than men. The apparent
rise in incidence may be attributed to better

diagnostic tools as well as the increased awareness of
these tumors. However, it is unclear if the rise in
incidence is due to etiological factors or simply better
diagnostic tools. Our incidence of BHTs differs from
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previously reported incidences of these tumors. Cresti
et al (2016) found incidence around 1.38 per 100,000
people while Sigurjonsson et al (2011) found an
incidence of 0.11 per 100,000 people.6,9 Both of these
studies examined different rates in different
populations, specifically primary benign and
malignant tumors in a European community from
1998 to 2010 and only cardiac myxomas in Europe,
respectively.6,9 Additionally, the timing of the Cresti
et al, (2016) does not match our study as we include a
longer time period.6,9 It is possible that during these
additional years these tumors were underdiagnosed..
The timing of between Sigurjonsson et al, (2011) and
our study does match more closely but the standard
population for age-adjusted are vastly different
(world standard population versus the U.S.
population). However, these differences likely do not
account for the entire disparity between the incidence
rates. Another U.S. based study provides a closer
estimate of 0.63 per million but this study only
evaluate primary malignant tumors.7 Primary
malignant tumors only account for a small percentage
of tumors so our estimated incidence is closer to what
we would expect based on malignant tumor data.1
Even so this does account for the apparent disparity
in cardiac tumors between U.S. and European
populations.
Based on our analysis these tumors are ill defined.
While a majority were patients admitting diagnoses
were benign or malignant tumors, we believe this
may represent an error in large number of cases.
BHTs are not apparent unless the patient has
previously undergone a diagnostic procedure and the
tumor had previously been discovered. Based on this
it is possible that the admitting diagnosis was not
defined, and the healthcare provider simply imputed
the final diagnosis. However, over one sixth of the
patients were admitted for a cardiac condition and
almost a quarter were admitted for an ill-defined
symptom.
The apparent 2 to 1 ratio of BHTs in women to
men is interesting but not usual and is consistent with
previous findings.3 It is currently unclear why a sex
difference exists for BHTs. The primary population
affected by BHTs in our study were over the age of
40, white and non-Hispanic. Additionally, while a
quarter of patients with BHTs were emergency
admissions and less than one third were urgent
admissions, most patients survived with limited
hospital stays.
While we have discharge records from inpatient
hospitalizations, these do not describe the entire
clinical picture. We do not have pathological reports
which would confirm these diagnoses. However,
these tumors are extremely rare, and it is unlikely that
Florida Public Health Review, 2019; 16, 147-151.
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they would misdiagnosed or miscoded. Future studies
should include pathological reports to describe the
incidence of BHTs by type. Another potential bias is
the recurrence of these tumors. Recurrence has been
reported in less than 5% of patients.2 With this
recurrence rate it is unlikely that it would have a
meaningful impact on the incidence of these tumors.
Furthermore, both limitations would cause the
incidence to appear higher than it is which would
widen the disparity between our report and the
European reports if these cases were identified.
Additionally, we are confident in our results as they
are similar in magnitude to reported malignant heart
tumors in the US.7 Another potential limitation is the
possibility of multiple visits per patient. However,
because once these tumors are found they are readily
removed it is unlikely that individuals would have
more than one visit. Furthermore, if patients had
more than one visit this would bolster our estimated
incidence and removal of these cases would further
separate our results from studies in Europe.
Therefore, it is unlikely that there were multiple
repeated visits for each patient.
Benign heart tumors are rare tumors that can
mimic cardiac conditions and can lead to disability
and death. We described the increasing incidence of
these tumors utilizing hospital discharge records
which may reflect increased awareness and better
diagnostic tools. The incidence described here is
similar in magnitude to other US reports but differs
from European reports. We believe this is due to
inherent differences in study design and diagnostic
procedures. Regardless, even with the incidence of
these tumors in question, the tumor etiology is
unknown and requires case-control studies to
examine etiological factors.
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